CL SMED A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Bankruptcy risk for industry  1.8% 1.8% 1.8% 1.8% 1.8%  
Bankruptcy risk  0.5% 0.6% 0.7% 0.7% 0.7%  
Credit score (0-100)  99 97 95 95 93  
Credit rating  AA AA AA AA AA  
Credit limit (kDKK)  1,656.8 1,873.6 1,430.4 1,177.4 1,392.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5

Net sales  0 0 0 0 0  
Gross profit  17,836 19,623 19,603 17,596 20,233  
EBITDA  6,628 7,839 6,704 5,283 6,916  
EBIT  6,152 7,260 6,079 4,761 6,147  
Pre-tax profit (PTP)  6,369.6 7,635.1 6,359.2 4,977.8 6,421.8  
Net earnings  4,960.1 5,942.2 4,945.3 3,871.2 4,998.3  
Pre-tax profit without non-rec. items  6,370 7,635 6,359 4,978 6,422  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5

Tangible assets total  1,065 1,500 1,108 2,112 1,767  
Shareholders equity total  9,331 10,373 8,018 5,890 7,388  
Interest-bearing liabilities  0.6 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  19,600 22,314 16,167 15,345 17,307  

Net Debt  -2,617 -3,766 -1,346 -2,390 -2,221  
 
See the entire balance sheet

Volume 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  17,836 19,623 19,603 17,596 20,233  
Gross profit growth  10.7% 10.0% -0.1% -10.2% 15.0%  
Employees  20 22 24 23 22  
Employee growth %  0.0% 10.0% 9.1% -4.2% -4.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  19,600 22,314 16,167 15,345 17,307  
Balance sheet change%  41.1% 13.8% -27.5% -5.1% 12.8%  
Added value  6,627.8 7,838.9 6,704.2 5,386.2 6,916.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -547 -143 -1,018 483 -1,052  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  34.5% 37.0% 31.0% 27.1% 30.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  38.2% 36.5% 33.2% 32.3% 40.1%  
ROI %  65.2% 68.2% 62.6% 68.5% 91.1%  
ROE %  55.4% 60.3% 53.8% 55.7% 75.3%  

Solidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Equity ratio %  47.6% 46.5% 49.6% 38.4% 42.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -39.5% -48.0% -20.1% -45.3% -32.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  100.8% 6,270.2% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Quick Ratio  2.0 2.0 1.9 1.4 1.6  
Current Ratio  2.0 2.0 2.0 1.5 1.7  
Cash and cash equivalent  2,617.2 3,765.5 1,346.3 2,390.4 2,221.2  

Capital use efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  9,372.7 10,215.4 7,265.0 4,055.6 6,048.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales / employee  0 0 0 0 0  
Added value / employee  331 356 279 234 314  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  331 356 279 230 314  
EBIT / employee  308 330 253 207 279  
Net earnings / employee  248 270 206 168 227